| Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration F Gonzalez-Ortiz, M Turton, PR Kac, D Smirnov, E Premi, R Ghidoni, ... Brain 146 (3), 1152-1165, 2023 | 84 | 2023 |
| Plasma and CSF biomarkers in a memory clinic: head‐to‐head comparison of phosphorylated tau immunoassays NJ Ashton, A Puig‐Pijoan, M Milà‐Alomà, A Fernández‐Lebrero, ... Alzheimer's & Dementia 19 (5), 1913-1924, 2023 | 62 | 2023 |
| Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications F Gonzalez-Ortiz, PR Kac, WS Brum, H Zetterberg, K Blennow, TK Karikari Molecular neurodegeneration 18 (1), 18, 2023 | 37 | 2023 |
| Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease PR Kac, F Gonzalez-Ortiz, J Simrén, N Dewit, E Vanmechelen, ... Alzheimer's Research & Therapy 14 (1), 65, 2022 | 30 | 2022 |
| Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid M Bilgel, Y An, KA Walker, AR Moghekar, NJ Ashton, PR Kac, TK Karikari, ... Alzheimer's & Dementia 19 (10), 4335-4345, 2023 | 21 | 2023 |
| Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease Y Yakoub, NJ Ashton, C Strikwerda‐Brown, L Montoliu‐Gaya, TK Karikari, ... Alzheimer's & Dementia 19 (12), 5620-5631, 2023 | 9 | 2023 |
| Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study L Montoliu-Gaya, D Alcolea, NJ Ashton, J Pegueroles, J Levin, B Bosch, ... EBioMedicine 90, 2023 | 9 | 2023 |
| Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development J Mlost, P Kac, M Kędziora, K Starowicz Neuropharmacology 204, 108908, 2022 | 9 | 2022 |
| A novel ultrasensitive assay for plasma p‐tau217: performance in individuals with subjective cognitive decline and early Alzheimer's disease F Gonzalez‐Ortiz, PCL Ferreira, A González‐Escalante, L Montoliu‐Gaya, ... Alzheimer's & Dementia 20 (2), 1239-1249, 2024 | 8 | 2024 |
| Association of serum brain-derived tau with clinical outcome and longitudinal change in patients with severe traumatic brain injury F Gonzalez-Ortiz, M Dulewicz, NJ Ashton, PR Kac, H Zetterberg, ... JAMA Network Open 6 (7), e2321554-e2321554, 2023 | 5 | 2023 |
| Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias F Gonzalez‐Ortiz, TK Karikari, GM Bentivenga, S Baiardi, A Mammana, ... Alzheimer's & Dementia 20 (1), 745-751, 2024 | 3 | 2024 |
| Preanalytical stability of plasma/serum brain‐derived tau F Gonzalez‐Ortiz, A Dias, M Turton, R Magalhães, PR Kac, M Correia, ... Alzheimer's & Dementia 19 (10), 4764-4770, 2023 | 3 | 2023 |
| Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease F Gonzalez-Ortiz, BE Kirsebom, J Contador, JE Tanley, P Selnes, ... Nature Communications 15 (1), 2908, 2024 | 2 | 2024 |
| Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology PR Kac, F González-Ortiz, A Emeršič, M Dulewicz, S Koutarapu, M Turton, ... Nature communications 15 (1), 2615, 2024 | 1 | 2024 |
| Longitudinal Blood Biomarker Trajectories in Preclinical Alzheimer’s Disease Y Yakoub, NJ Ashton, TK Karikari, C Strikwerda‐Brown, L Montoliu‐Gaya, ... Alzheimer's & Dementia 18, e064811, 2022 | 1 | 2022 |
| Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates T Islam, H Kvartsberg, A Sehrawat, PR Kac, B Becker, M Olsson, ... Alzheimer's & Dementia, 2024 | | 2024 |
| Plasma p‐tau212 is an early biomarker to identify Alzheimer’s Disease pathology in Down Syndrome PR Kac, D Alcolea, L Montoliu‐Gaya, JL Rodriguez, F Gonzalez‐Ortiz, ... Alzheimer's & Dementia 19, e076229, 2023 | | 2023 |
| Microtubule‐binding region tau fragment tau368 as a biomarker of Alzheimer’s disease J Simrén, S Janelidze, PR Kac, TK Karikari, D Smirnov, H Kvartsberg, ... Alzheimer's & Dementia 19, e079611, 2023 | | 2023 |
| Plasma biomarkers in relation to spatial distribution of Alzheimer’s disease neuropathology M Bilgel, I Shah, KA Walker, A Moghekar, NJ Ashton, PR Kac, TK Karikari, ... Alzheimer's & Dementia 19, e078416, 2023 | | 2023 |
| Biomarkers of aberrant tau phosphorylation are increased in primary progressive multiple sclerosis A Emersic, PR Kac, F Gonzalez-Ortiz, M Dulewicz, NJ Ashton, GB Jakob, ... MULTIPLE SCLEROSIS JOURNAL 29, 1111-1111, 2023 | | 2023 |
